Drug policy news covering legalization efforts, DEA enforcement, opioid crisis, marijuana laws, and substance regulation developments.
The number of young British nationals arrested abroad for drug smuggling more than quadrupled from 80 in 2023 to over 340 in 2025, driven by cannabis from Thailand. Detentions have risen sharply across south-east Asia, including Thailand, Malaysia, Cambodia, and Laos, prompting Foreign Office minister Stephen Doughty to warn of harsh penalties including prison or the death penalty.
Attorney General Todd Blanche has pledged to charge drug dealers who sell fentanyl-laced pills as murderers, citing the recent death of actress Hayden Panettiere. Blanche stated that proving a dealer sold a lethal pill to a victim constitutes a federal crime punishable by prison, marking a significant escalation in the legal response to the opioid crisis.
AFP Commissioner Krissy Barrett argues for a national conversation linking illicit drug use to organized crime violence, citing recent mistaken-identity murders in Sydney. She suggests Australians are now more receptive to this message following shocking shootings, urging the refusal to normalize drug use as a matter of national security.
The article contends that Ghana is emerging as a critical transit hub for international drug trafficking, citing a recent seizure of 3.9 tonnes of cocaine destined for Belgium. It suggests that persistent smuggling operations linked to fugitives like Jos Leijdekkers indicate systemic failures requiring urgent investigation by Ghanaian authorities.
Thomas Gilbert Jr. argues that Massachusetts should reconsider its recreational cannabis legalization due to severe public health risks. Citing personal experience and studies on adolescent cognitive deficits and psychiatric emergencies, he contends that the current system fails to protect young people and harms low-income communities, urging voters to address these negative outcomes.
The author argues that while cannabis risks are real, prohibition is inferior to regulation. The piece critiques Dr. Jeffrey Morgan’s economic and safety claims as lacking independent verification, contending that a regulated market with oversight better serves public policy than an illicit one.